Scheme 1From: Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPCPotential structures of the LysoPC which was elevated in serum of IPF patients compared to controls. For simplification, only the sn-1 isomers are representedBack to article page